Scarica l'app Stockscreener
50.55
0.52%
0.22
Pulse Biosciences Inc Borsa (PLSE) Ultime notizie
Total assets of Pulse Biosciences, Inc. – HAM:6L8 - TradingView
Operating cash flow per share of Pulse Biosciences, Inc. – HAM:6L8 - TradingView
Pulse Biosciences stock hits all-time high at 48.92 USD - Investing.com
$Pulse Biosciences (PLSE.US)$ shorties getting squeezed - Moomoo
Pulse (PLSE) Results Review: EPS Clears the Reported Estimate; Trading Move: Shares Rise 2.22% in the Latest ReadingDividend Growth Analysis - Vinanet
Bank of America Corp DE Grows Stake in Pulse Biosciences, Inc $PLSE - MarketBeat
Pulse Biosciences (PLSE) Launched A $75 Million Offering, Is The Upside Already Priced In? - Sahm
Pulse Biosciences (NASDAQ:PLSE) Sets New 1-Year HighHere's Why - MarketBeat
Pulse (PLSE) Earnings Review: EPS Exceeds Its Estimate in the Current Update; Reaction Snapshot - vinanet.vn
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 18, 2026 - BioSpace
Pulse Biosciences (PLSE) Grants Equity Awards to New Hires Amid High Price-to-Sales Valuation - GuruFocus
This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Sahm
This Okta Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday - Benzinga
Pulse Biosciences, Inc (NASDAQ:PLSE) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Needham & Company LLC Initiates Coverage on Pulse Biosciences (NASDAQ:PLSE) - MarketBeat
PLSE Initiates Coverage On by Needham -- Price Target Announced at $58.00 - GuruFocus
Needham initiates Pulse Biosciences stock with buy on ablation tech By Investing.com - Investing.com Canada
Needham Initiates Pulse Biosciences at Buy With $58 Price Target - marketscreener.com
PULSE BIOSCIENCES INC : NEEDHAM INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $58 - Bitget
Pulse Biosciences (PLSE) Is Up 5.0% After Wider Losses And $75M ATM Plan Filed – Has The Bull Case Changed? - simplywall.st
Pulse Biosciences (PLSE) Stock Looks Pricey On Book Value Yet Strong On Returns - Yahoo Finance
Pulse Biosciences Eyes AFib Breakthrough With Nanosecond PFA Platform - marketbeat.com
(PLSE) Risk Channels and Responsive Allocation - Stock Traders Daily
Pulse Biosciences (PLSE) Prices A $75 Million Offering, Is The Stock Fully Valued? - Yahoo Finance
PLSE Virtual Meeting on Strategic Initiatives Highlights Growth Expectations Despite High Valuation - GuruFocus
Pulse Biosciences (PLSE) Q2 2026 Earnings Call Transcript - AOL.ca
Pulse Biosciences stock reaches all-time high at 46.03 USD By Investing.com - Investing.com Australia
Pulse Biosciences stock reaches all-time high at 46.03 USD - Investing.com
$Pulse Biosciences (PLSE.US)$ SQUEEZING THE SHORTIES - Moomoo
Pulse Biosciences at Canaccord Genuity conference: nsPFA push gains pace By Investing.com - Investing.com Canada
PLSE: nsPFA technology delivers breakthrough efficacy in AFib and is poised for broad clinical adoption - TradingView
Pulse Biosciences, Inc. (PLSE) Stock Analysis: Exploring the Innovative Potential of a $2.96 Billion Bioelectric Medicine Leader - DirectorsTalk Interviews
PLSE to Join BTIG Virtual Meeting Amid Elevated Price-to-Sales V - GuruFocus
PLSE Maintains Buy Rating by Canaccord Genuity -- Price Target R - GuruFocus
Canaccord Genuity Group Issues Positive Forecast for Pulse Biosciences (NASDAQ:PLSE) Stock Price - MarketBeat
Canaccord raises Pulse Biosciences stock price target on clinical progress - Investing.com India
Canaccord raises Pulse Biosciences stock price target on clinical progress By Investing.com - Investing.com Canada
Weekly Recap: Q2 losses, ATM raises and NANOPULSE-AF study past halfway - TradingView
Pulse Biosciences (NASDAQ:PLSE) Announces Earnings Results, Misses Estimates By $0.07 EPS - MarketBeat
Pulse Biosciences, Inc. (PLSE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Pulse Biosciences (NASDAQ:PLSE) Stock Rating Lowered by Wall Street Zen - MarketBeat
Q2 2026 Pulse Biosciences Inc Earnings Call Transcript - GuruFocus
Pulse Biosciences, Inc. (PLSE) stock price, news, quote and history - uk.finance.yahoo.com
Sector Update: Healthcare - Moomoo
Pulse Biosciences Shares Rise After Q2 Results - marketscreener.com
Pulse Biosciences (NASDAQ:PLSE) Trading Up 15.7%Should You Buy? - MarketBeat
Pulse Biosciences enters $75 million equity distribution agreement with Mizuho - Investing.com Australia
Pulse Biosciences, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Pulse Biosciences (PLSE) Accelerates Clinical Enrollment, Market Pricing Reflects High Growth Expectations - GuruFocus
Earnings call transcript: Pulse Biosciences misses Q2 2026 estimates but gains on trial progress - Investing.com Canada
Form 8K Pulse Biosciences Inc For: 6 August By Investing.com - Investing.com Nigeria
Pulse Biosciences Inc (PLSE) (Q2 2026) Earnings Call Highlights: - GuruFocus
Did Pulse Biosciences (PLSE) Miss Revenue Estimates Despite Cash Influx? GF Score: 31/100 - GuruFocus
Pulse Biosciences Q2 Earnings Call Highlights - TradingView
Pulse Biosciences Q2 2026 Earnings Call Transcript - MarketBeat
Pulse Biosciences Inc (PLSE) (Q2 2026) Earnings Call Highlights: Accelerated Enrollment and ... - Yahoo Finance
Pulse Biosciences, Inc (PLSE) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Pulse Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Pulse Biosciences earnings missed by $0.08, revenue fell short of estimates - Investing.com Canada
Earnings Flash (PLSE) Pulse Biosciences, Inc. Reports Q2 Revenue $0.4M, vs. FactSet Est of $533K - marketscreener.com
0.35%
2.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):